Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00734487 · ClinicalTrials.gov registry record
AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
A clinical trial of Age-related Macular Degeneration, sponsored by Duke University.
- Completed
- Registry status
- 470
- Enrollment target
- 4
- Study locations
NCT00734487 is a study of Age-related Macular Degeneration that has completed, run by Duke University. The registered enrollment target is 470 participants, below the 1,501-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (69% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT00734487, a study of Age-related Macular Degeneration, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 470 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to identify whether changes in age-related macular degeneration (AMD) over time as seen with spectral domain optical coherence tomography (SDOCT) imaging, can be used to predict vision loss and the advancement of AMD in people at moderate to high risk for progression.
Conditions Studied
Study Locations (4)
Georgia
- Emory University Eye Center - Atlanta
Maryland
- National Eye Institute - Bethesda
North Carolina
- Duke University Eye Center - Durham
Oregon
- Devers Eye Center - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 470 participants |
| Start Date | 2008-06 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00734487
The ClinicalTrials.gov registry entry for NCT00734487 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 470 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,501-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (69% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 0 interventions.
NCT00734487 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Georgia, Maryland, North Carolina.
Frequently Asked Questions
What is clinical trial NCT00734487 about?
NCT00734487 is a clinical study titled "AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study". The purpose of this study is to identify whether changes in age-related macular degeneration (AMD) over time as seen with spectral domain optical coherence tomography (SDOCT) imaging, can be used to predict vision loss and the advancement of AMD in people at moderate to high risk for progression.
What is the current status of trial NCT00734487?
This trial is currently completed. The enrollment target is 470 participants. The study started on 2008-06. Estimated completion is 2015-08.
What conditions does trial NCT00734487 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration.
Who is sponsoring clinical trial NCT00734487?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00734487 being conducted?
This trial has 4 study locations across Georgia, Maryland, North Carolina, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
High Resolution Retinal Imaging
RECRUITING
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.